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Type 2 diabetes is associated with signiﬁcantly accelerated rates of micro- and macrovascular complications such as diabetic
vascularinﬂammationandendothelialdysfunction.Inthepresentstudy,weinvestigatedtheprotectiveeﬀectoftheaqueousextract
of Portulaca oleracea L. (AP), an edible plant used as a folk medicine, on diabetic vascular complications. The db/db mice were
treatedwithAP(300mg/kg/day,p.o.)for10weeks,andAPtreatmentmarkedlyloweredbloodglucose,plasmatriglyceride,plasma
levelofLDL-cholesterol,andsystolicbloodpressureindiabeticdb/dbmice.Furthermore,APsigniﬁcantlyincreasedplasmalevelof
HDL-cholesterol and insulin level. The impairment of ACh- and SNP-induced vascular relaxation of aortic rings were ameliorated
by AP treatment in diabetic db/db mice. This study also showed that overexpression of VCAM-1, ICAM-1, E-selectin, MMP-2,
and ET-1 were observed in aortic tissues of untreated db/db mice, which were signiﬁcantly suppressed by treatment with AP. We
also found that the insulin immunoreactivity of the pancreatic islets remarkably increased in AP treated db/db mice compared
with untreated db/db mice. Taken together, AP suppresses hyperglycemia and diabetic vascular inﬂammation, and prevents the
development of diabetic endothelial dysfunction for the development of diabetes and its vascular complications.
1.Introduction
Macrovascular complications including atherosclerosis are
the leading cause of morbidity and mortality in patients with
diabetes mellitus (DM) [1, 2]. The endothelium is an early
target in diabetes, and dysfunction of endothelial cells plays
an important role in the diabetic vascular complications
[3]. Hypertension, an impaired endothelium-dependent va-
sodilation, has been identiﬁed as an independent risk factor
for the development of endothelial dysfunction and inﬂam-
mation. Endothelin-1 (ET-1), a potent vasoconstrictor with
proﬁbrotic properties, is chronically elevated in diabetes.
Recent study indicated that an increased endothelin-1 level
of plasma is involved in diabetic complications [4]. In car-
diovascular disease, the matrix metalloproteinases (MMPs)
can result in a tissue injury and inﬂammation. An increased
MMP activity contributes to cardiac and vascular complica-
tions in experimental hypertensionandatherosclerosismod-
els [5, 6].
Inﬂammatory cytokines and adhesion molecules seem to
play main roles in the pathogenesis of atherosclerosis and
diabetic vascular complications [7]. Adhesion of monocyte
and endothelial cell is an important early event in vascular
inﬂammation [8, 9]. In the process of inﬂammation, mono-
cytes are recruited to sites of endothelial cell injury and roll
along the vascular endothelium, where they become acti-
vated by surface-bound chemokines. The monocytes adhere
strongly to the vascular endothelium and transfer through
the endothelial cells monolayer [10, 11]. Molecules such as
endothelial vascular cell adhesion molecule-1 (VCAM-1),2 Evidence-Based Complementary and Alternative Medicine
intercellular adhesion molecule-1 (ICAM-1), and E-selectin
mediate the adhesion of monocytes [12]. db/db mice have a
point mutation in the leptin receptor gene and are a well-
established model of type 2 diabetes. The mice are obese,
hyperglycemic, and insulin resistant at early age and progress
to more severe diabetes, resembling type 1 diabetes with a
pancreaticbetacelldysfunctionafter16weeksofage[13,14].
Portulaca oleracea L. (Portulacaceae) is an edible plant
and has been used as a folk medicine in many countries, act-
ing as a diuretic, febrifuge, antiseptic, antispasmodic, and
vermifuge [15, 16]. It has been shown to play pharmacolog-
ical roles, including antibacterial [17], analgesic [18], skeletal
muscle-relaxant [19], and wound-healing [20] activities.
Many studies have also shown that the major bioactive com-
ponents of Portulaca oleracea are ﬂavonoids, coumarins,
monoterpene glycoside, and alkaloids [21, 22]. Some re-
search results indicated that Portulaca oleracea could also
be used to reduce the incidence of cardiovascular diseases
[23]. Thus, the purpose of this study was to examine the
protective eﬀect of an aqueous extract of Portulaca oleracea
(AP)againsthyperglycemia,diabeticmetabolicdisorder,and
diabetic vascular complications in diabetic db/db mice.
2.MaterialsandMethods
2.1. Extraction of Portulaca oleracea . The Portulaca oleracea
was purchased from the Herbal Medicine Co-operative
Association in Jeonbuk Province, Korea. Herbarium voucher
specimen (No. HBE121) was deposited in the herbarium
of the Professional Graduate School of Oriental Medicine,
Wonkwang University, Iksan, Jeonbuk, South Korea. Dried
aerial parts of P. oleracea (400g) was extracted with 5.5L of
boiled distilled water at 100◦Cf o r2h .T h ea q u e o u se x t r a c t
was centrifuged at 1,000g for 20min at 4◦Ca n ds u p e r -
natant was ﬁltered with Whatman No. 3 ﬁlter paper, and
then concentrated using rotary evaporator. The supernatant
extract was lyophilized to produce a powder, which was then
kept at 4◦C until using this experiment. The yield of the
water extract of P. oleracea was approximately 22.8% of plant
powder.
2.2.ExperimentalAnimals. MaleC57BL/KsJ-db/dbmiceand
wild-type C57BL/6J mice were obtained from the Central
Lab. Animal Inc. (Seoul, Korea) at age 6 weeks. At 8 weeks of
age, fasting blood glucose was determined in each mice, and
then divided into four groups with 10 mice; wild type mice,
db/db mice, db/db mice treated with AP (300mg/kg/day,
p.o.) and db/db mice treated with rosiglitazone by sonde
(Alexis Biochemicals, San Diego, CA, USA; 10mg/kg/day,
p.o. ﬁnal volume 0.3mL). The peroxisome proliferator-acti-
vated receptor-γ (PPAR-γ) agonist, rosiglitazone was chosen
as a positive control, which is an anti-diabetic agent for the
treatment of type 2 diabetes. All mice fed the puriﬁed AIN-
76A rodent diet (Dyets, Inc., Bethlehem, PA, USA) for 10
weeks. All mice were maintained under standard light (12h
light/dark),temperature(22±2◦C)andhumidity(40±10%)
condition. All procedures were approved by the Institutional
Animal Care and Utilization Committee for Medical Science
of Wonkwang University.
2.3.PlasmaBiochemicalAnalysis. Thebloodgl uc osec o nc e n-
tration was measured with the whole blood obtained from
the tail veins after withholding food for 6h using a Onetouch
Ultra Blood Glucose Meter and Test Strip (LifeScan Inc., CA,
USA). Blood samples were taken by periorbital vein for bio-
chemical analysis. Plasma insulin levels were measured based
on ELISA method using commercial mice insulin ELISA kit
(Shibyagi Co., Gunma, Japan). The total cholesterol, HDL
cholesterol,LDLcholesterol,andtriglyceridelevelsinplasma
were measured enzymatically using commercially available
kits (Wako Pure Chemical Industries, Osaka, Japan).
2.4. Measurement of Systolic Blood Pressure. Systolic blood
pressure (SBP) and heart rate were determined while
mice were conscious using a noninvasive tail-cuﬀ monitor
(MK2000; Muromachi Kikai, Tokyo, Japan). Values are
presented as the mean ± SEM of ﬁve measurements.
2.5. Preparation of Aortic Rings. T h em i c ea o r t a ew e r ec a r e -
fully dissected and placed into ice-cold Kreb’s solution
(pH 7.4) containing 118mM NaCl, 4.7mM KCl, 1.1mM
MgSO4,1 . 2m MK H 2PO4,1 . 5m MC a C l 2,2 5m MN a H C O 3,
and 10mM glucose. The aortae were removed free of con-
nective tissue and fat and then cut into rings with a width
of approximately 2-3mm. All dissecting procedures were
carried out carefully to protect the endothelium from un-
intentional damage. Endothelial relaxant response was mea-
sured by responding ACh and SNP on phenylephrine-
(1μM)-induced aortic rings [24].
2.6. Recording of Isometric Vascular Tone. The aortic rings
were suspended, by means of two L-shaped stainless-steel
wires inserted into the lumen, in a tissue bath containing
Kreb’s solution (pH 7.4) at 37◦C.
Mixed gas contained 95% O2, and 5% CO2 was continu-
ously bubbled through the bath. The baseline load placed on
the aortic rings was 1.0g. Changes in isometric tension were
recordedusingaforcedisplacementtransducer(GrassFT03,
Quincy, MA) connected to a Grass polygraph recording sys-
tem (Model 7E). The aortic rings were washed every 10min
with Kreb’s solution until the tension returned to the basal
level. After stabilized, the aortic rings were contracted with
phenylephrine (1μM) to obtain a maximal response, and
then a concentration-dependent response curve to acetyl-
choline (Ach) and sodium nitroprusside (SNP) was deter-
mined in thoracic aorta, respectively.
2.7. Western Blot Analysis. Aortae were homogenized with a
buﬀer containing 250mM sucrose, 10mM triethanolamine,
10mM acetic acid, 1mM EDTA, 1mM phenylmethylsul-
fonyl ﬂuoride (PMSF), 1mM benzamidine hydro-chlo-
ride hydrate, and 1mM dithiothreitol, at pH 7.4. The homo-
genates were then centrifuged at 8,000rpm for 10min at
4◦C, and the supernatant was centrifuged at 13,000rpm
for 5min at 4◦C. The proteins were separated by 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to Hybond-ECL nitrocellulose
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were blocked with 5% nonfat milk for 1h and then probed
primary antibodies with ICAM-1, VCAM-1, E-selectin,
and MMP-2 (1:1000; Santa Cruz Biotechnology, CA) for
overnightat4◦C.AfterwashingwithTBST,theywereprobed
with horseradish peroxidase-conjugated secondary antibody.
The immunoreactive bands were visualized using ECL kit
(Upstate Biotechnology, Lake Placid, NY) according to the
manufacturer’s instructions and quantiﬁed using a Chemi-
Doc image analyzer (Bio-Rad, Hercules, CA).
2.8. Immunoﬂorescence Staining of Insulin in Pancreatic Islets.
Slides of the pancreatic frozen section were incubated with
10% nonimmune goat serum for 1h at room temperature
to block nonspeciﬁc staining, and incubated with a primary
antibodies of insulin (1:100, Santa Cruz Biotechnology)
for overnight at 4◦C. After washing, ﬂuorescein-conjugated
goat anti-rabbit IgG and Alexa Fluor 594-conjugated donkey
anti-goat IgG (1:200, Molecular Probes, Carlsbad, CA) were
incubated for 1h at room temperature. After washing at 3
times, the sections were mounted and observed by Olympus
ﬂuorescence microscopy. The expressions of insulin in pan-
creas were observed by Olympus microscopy equipped with
an Olympus DP 70 camera. For the quantitative analysis, the
average score of 10–20 randomly selected area was calculated
using NIH Image analysis software, Image J (NIH, Bethesda,
MD).
2.9. Immunohistochemical Staining of VCAM-1 and ET-1 in
Aortic Tissue. Isolated aortic tissues were ﬁxed by immersion
in 4% paraformaldehyde for 48h at 4◦C and incubated with
30% sucrose for 2 days. Each aorta was embedded in OCT
compound (Tissue-Tek, Sakura Finetek, Torrance, CA), fro-
zen in liquid nitrogen, and stored at −70◦C. Frozen sections,
10μm thick, were cut with a Shandon Cryotome SME
(Thermo Electron Corporation, Pittsburg, PA) and placed
onpoly-L-lysine-coatedslides.Theslideswereairdriedover-
night at room temperature, wrapped, and stored at −70◦C
until immunostaining. Slides were immunostained by Invit-
rogen’s Histostain-SP kits using the Labeled-Strept-avidin-
Biotin (LAB-SA) method. Slides were immersed in 3% hy-
drogen peroxide for 1min at room temperature to block
endogenous peroxidase activity and rinsed with PBS. And
then, slides were incubated with 10% nonimmune goat se-
rum for 20min at room temperature to block nonspeciﬁc
staining and incubated with a primary antibodies of VCAM-
1 (1:500; Chemicon International Inc., Temecula, CA),
ET-1 (1:500; Oncogene, CA) in humidiﬁed chambers for
overnight at 4◦C. All slides were incubated with biotiny-
lated secondary antibody for 20min at room temperature
and then incubated with horseradish peroxidase-conjugated
streptavidin for 20min at room temperature, followed by
detection with 3-amino-9-ethylcarbazole (AEC) as chro-
mogen and counterstaining with hematoxylin (Zymed, CA).
For the quantitative analysis, the average score of 10–20
randomly selected area was calculated using NIH Image
analysis software, Image J (NIH, Bethesda, MD).
2.10. Statistical Analysis. Values are shown as mean ± SE.















































Values are expressed as mean ± SE (n = 10); ∗∗P<0.01 versus WT;
#P<0.05, ##P<0.01 versus db/db control.
followed by the Student’s t-test and one-way ANOVA. Diﬀer-
ences with a value of P<0.05 were considered statistically
signiﬁcant.
3. Results
3.1. Eﬀect of AP on Blood Glucose Level. The blood glucose
level of untreated db/db mice was signiﬁcantly higher than
thatofthewild-typemiceduringentireexperimentalperiod.
Interestingly, the blood glucose levels were markedly reduced
in AP-treated db/db mice compared to the untreated db/db
mice over the 12 weeks of age. Similarly, these levels of RG-
treated db/db mice were signiﬁcantly decreased over the 10
weeks of age (Figure 1). No mortality was observed, and AP
was found to be safe at given doses.
3.2. Eﬀect of AP on Systolic Blood Pressure. The systolic blood
pressure (SBP) level after 4 weeks of treatment signiﬁcantly
increased in untreated db/db mice. The AP-treated db/db
miceshowedasigniﬁcantdecreaseintheSBPlevelcompared
with the untreated db/db mice during all the experimental
period. As similar in level, the RG-treated db/db mice indi-
cated a remarkable decrease in that level compared to the
untreated db/db mice (Figure 2).
3.3. Eﬀect of AP on Vascular Tension. Vascular responses to
ACh (1 × 10
−10 to 1 × 10
−7 M) and SNP (1 × 10
−11 to
1 × 10
−8 M) were measured in thoracic aorta. Endothelium-
de-pendent relaxant responses to Ach were signiﬁcantly
impaired in the untreated db/db mice compared to wild-
type mice. The impairment of vasorelaxation was markedly
ameliorated by treatment with AP (Figure 3(a)). Simi-
larly, smooth muscle dilatory responses to SNP markedly
decreased in the untreated db/db mice compared to wild-
type mice, which were signiﬁcantly recovered by treatment
with AP (Figure 3(b)).4 Evidence-Based Complementary and Alternative Medicine
















































Figure 2: Eﬀect of AP on weekly systolic blood pressure levels in db/db mice. Values are expressed as mean ± SE (n = 10); ∗P<0.05,
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Figure 3: Eﬀect of AP on the ACh-induced (a) and SNP-induced (b) relaxation of thoracic aorta from db/db mice. Values are expressed as






































































Figure 4: Eﬀect of AP on HDL cholesterol (a), triglyceride (b), and LDL cholesterol (c) levels of plasma in db/db mice. Values are expressed


















































































































































































































































































Figure 5: Eﬀect of AP on ICAM-1 (a), VCAM-1 (b), E-selectin (c), and MMP-2 (d) expression in the aorta of db/db mice. Western blots
and corresponding densitometric analyses of ICAM-1, VCAM-1, E-selectin, and MMP-2 in aortic tissue. Values are expressed as mean ± SE
(n = 3); ∗∗P<0.01 versus WT; ##P<0.01 versus db/db control.
3.4. Eﬀe c to fA Po nP l a s m aB i o m a r k e r .The plasma insulin
level was measured at the end of the study. Our results
showed that the plasma insulin level of the AP-treated db/db
mice was signiﬁcantly higher than that of the untreated
db/db mice. Therefore, treatment with AP markedly inhib-
ited the age-related decrease of plasma insulin level in db/db
mice. The plasma insulin level of the RG-treated db/db mice
was signiﬁcantly higher than that of the untreated db/db
mice (data not shown). The plasma triglyceride and low-
density lipoprotein (LDL) cholesterol levels of the untreated
db/db mice signiﬁcantly increased compared with wild-
type mice. The treatment with AP signiﬁcantly lowered
these levels in the db/db mice (Figures 4(b) and 4(c)). In
contrast, treatment with AP markedly increased the high-
density lipoprotein (HDL) cholesterol in the db/db mice





db/db +RG db/db +AP
(a) (b) (c) (d)


































































db/db +RG db/db +AP
(C)
Figure 6: Eﬀect of AP on VCAM-1 and ET-1 immunoreactivity in the aorta of db/db mice. (A) Immunohistochemical staining of VCAM-1
or ET-1 in aorta from (a, e) WT, (b, f) untreated db/db mice, (e, g) db/db mice treated with rosiglitazone (10mg/kg/day), and (d, h) db/db
mice treated with AP (300mg/kg/day). Lower panels show quantitative analysis of VCAM-1- (B) and ET-1- (C) -positive area. The average
score of 5–10 randomly selected sites per section of aorta was calculated. Data expressed as mean ± SE; ∗∗P<0.01 versus WT; ##P<0.01
versus db/db control. Original magniﬁcation:1000x.
3.5. Eﬀect of AP on Vascular Inﬂammation in Aortic Tis-
sue. Vascular adhesion molecules, ICAM-1 (Figure 5(a)),
VCAM-1 (Figure 5(b)), and E-selectin (Figure 5(c))w e r e
evaluated quantitatively in aortic tissue by Western blot
analysis. Expressions of ICAM-1, VCAM-1, and E-selectin in
untreated db/db mice signiﬁcantly increased compared with
wild-type mice, respectively. However, treatment with AP
eﬀectivelyreducedtheexpressionsofICAM-1,VCAM-1,and
E-selectinindb/dbmice.Matrixmetalloproteinase-(MMP-)
2 was also measured using Western blot in aortic tissue.
MMP-2 induced degradation of proteins in the extracellular
matrix. In untreated db/db mice, expression of MMP-
2 markedly increased compared with wild-type mice. AP
treatment signiﬁcantly lowered this overexpression level in
db/db mice (Figure 5(d)).
Immunohistochemical staining showed that VCAM-1
and ET-1 were overexpressed in the aortic endothelial
layers of untreated db/db mice compared with wild-type
mice, which were markedly reduced by treatment with AP
(Figure 6).
3.6. Eﬀe c to fA Po nI m m u n o r e a c t i v i t yf o rI n s u l i ni nP a n c r e a t i c
Islets. In untreated db/db mice, immunoﬂuorescent staining
ofthepancreatictissuesrepresentedweakinsulinimmunore-
activityintheisletsofLangerhans.InAP-treateddb/dbmice,
there was an indicated strong insulin immunoreactivity in
the islets of Langerhans (Figure 7).
4. Discussion
In the present study, we clearly demonstrate that the aqueous
extract of Portulaca oleracea (AP) has an antidiabetic eﬀect
by prevention of the developed diabetic symptoms and sup-
pression of diabetic vascular complications in type 2 diabetic
db/db mice. Diabetes is associated with signiﬁcantly acceler-
atedratesofcardiovascularcomplicationssuchasatheroscle-
rosis and hypertension. Recent studies indicate that diabetic
atherosclerosis is not simply a disease of hyperlipidemia but
also an inﬂammatory disorder [1, 25]. Large clinical trials
in both type 1 and type 2 diabetes have also showed that































































Figure 7: Immunoﬂuorescence staining of insulin in the pancreas. Representative histological sections of pancreatic islets of (a) WT, (b)
untreated db/db mice, (c) db/db mice treated with rosiglitazone (10mg/kg/day), and (d) db/db mice treated with AP (300mg/kg/day)
incubated with anti-insulin antibodies. (B) Quantitative analysis of insulin-positive area. Data expressed as mean ± SE (n = 5); ∗∗P<0.01
versus WT; ##P<0.01 versus db/db control. Original magniﬁcation:1000x.
vascular complications. In addition, type 2 diabetes occurs
in the cluster of cardiovascular risk factors, hypertension,
hightriglyceridelevels,lowHDL-cholesterollevels,increased
LDL-cholesterol levels, hyperinsulinemia, insulin resistance,
and chronic inﬂammation, all of which accelerate diabetic
vascular complications [26]. All of these factors induce a
state of constant and progressive damage to the vascular
wall, indicated by inﬂammatory process and endothelial
dysfunction [27]. Accordingly, endothelial dysfunction and
inﬂammation in Type 2 diabetes are progressive and closely
interrelated [28]. Endothelial dysfunction was initially iden-
tiﬁed as impaired vasodilation to speciﬁc stimuli such as
ACh or bradykinin; therefore, improvement of endothelial
function is predicted to regulate lipid homeostasis [29]. Our
results showed that AP treatment markedly reduced blood
glucose, triglyceride, LDL cholesterol, and systolic blood
pressure levels in diabetic db/db mice. Furthermore, treat-
mentwithAPsigniﬁcantlyincreasedthelevelofHDLcholes-
terol in diabetic db/db mice. The endothelium can sense
changes or abnormalities in blood ﬂows and pressures, and
vascular endothelium exists between circulating blood and
vascular smooth muscle is playing the important role in
modulation of vascular tone [30]. Impaired relaxation of
aorta was induced by ACh in obese diabetic fatty rats as
a consequence of endothelial dysfunction [28, 31]. In our
data, the impairment of acetylcholine- (ACh-) and sodium-
nitroprusside- (SNP-) induced vascular relaxation of aortic
rings in diabetic db/db mice was ameliorated by treatment
with AP. Vasoconstrictor endothelin (ET)-1 expression was
signiﬁcantly increased in the aorta in db/db mice; however,
treatment with AP markedly decreased the levels of ET-1.
In addition, impaired acetylcholine-dependent vasodilation
was recently associated with increased levels of the plasma
soluble E-selectin and P-selectin in essential hypertension.
COX-2 upregulation and vascular smooth muscle contractile
hyperreactivity were reported in spontaneous diabetic db/db
mice [32]. We showed the overexpression of VCAM-1, inter-
cellular cell adhesion molecule- (ICAM-) 1, E-selectin, and
MMP-2 in aortic tissue of untreated db/db mice. Inter-
estingly, treatment with AP signiﬁcantly suppressed these
expressions. It suggested that diabetic endothelial dysfunc-
tion was related with vascular inﬂammation, and AP treat-
ment recovered it. These ﬁndings, at least in part, indicate
that AP may protect against the initiation and development
of diabetic atherosclerosis by improving lipid homeostasis.
Plasma insulin levels of db/db mice are known to be age
dependent. However, when the db/db mice reach at 12 to
24 weeks old, islet develops β-cell necrosis, hyperinsulinemia
is diminished, and the mice manifest symptoms of insulin
deﬁciency[33].Type2diabetesischaracterizedbypancreatic
β-celldysfunction.Normalpancreaticβcellscancompensate
for the insulin resistance by increasing insulin secretion.
However, extensive exposure of pancreatic β cells induced by
high glucose levels induces β-cell dysfunction that is asso-
ciated with reduced insulin secretion [34]. In the present
study, we observed that plasma insulin concentration was
signiﬁcantly higher in the AP-treated db/db mice compared
to the untreated db/db mice. Therefore, these data suggest
that the plasma insulin level in the db/db mice may be grad-
ually declined, whereas AP may inhibit the age-dependent
insulin reduction by a reduction of β-cell mass. Moreover,
in untreated db/db mice, immunostaining of the pancreatic8 Evidence-Based Complementary and Alternative Medicine
tissues represented weak insulin secretion in the islets of
Langerhans. However, there was an indicated strong insulin
secretion in the islets of Langerhans by treatment with AP. A
previous study demonstrated that P. oleracea extract exhib-
ited potent antioxidant property in streptozotocin diabetic
rats. However, it showed only moderate antidiabetic activity
[35]. In addition, AP not ethanolic extract signiﬁcantly
inhibited DNA damage in human lymphocytes [36]. The
present study demonstrated that AP exhibited hypoglycemic
action more than rosiglitazone in db/db mice. These results
suggested that vascular protective role of AP may be involved
in type 2 diabetes. Further study is required to clarify the
mechanism of AP in db/db mice.
Takentogether,aerialpartsofP. oleracea treatmentmark-
edly ameliorated hyperglycemia and impairment of insulin
secretionandpreventeddiabeticendothelialdysfunctionand
vascular inﬂammation in type 2 diabetic db/db mice. In con-
clusion, AP has an antihyperglycemic eﬀect and preventive
eﬀect on pathological mechanism of diabetic vascular com-
plications. These ﬁndings support the palliative eﬀect of AP
in the development of diabetes and its vascular complica-
tions.
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